Close
Help
Login
Staff Login
Register
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
AstraZeneca vaccine to remain authorized in Canada
AstraZeneca vaccine to remain authorized in Canada
AstraZeneca vaccine to remain authorized in Canada
Standard Video
Actions
Overview
Conceptually Similar Documents
CP118971421 | AstraZeneca vaccine authorized in Canada
CP120476771 | AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
CP118972171 | Newsroom Ready: AstraZeneca vaccine authorized in Canada
CP122017117 | AstraZeneca blood clot risk remains low: Tam
CP123251321 | Ontario to get more than 250,000 AstraZeneca doses
CP123262421 | N.S. pauses use of AstraZeneca vaccine
CP123774871 | Ontario to resume AstraZeneca shots for COVID-19 as second dose
CP122404571 | Quebec reports first blood clot death in woman who received AstraZeneca vaccine
CP122830710 | New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine
CP119781421 | N.S. to start administering AstraZeneca vaccines
City
Vaughan
Country
Canada
Add to cart
Select usage
Type of video?
For editorial use only. Video needs to be used in its entirety (i.e. use of select segment(s) not allowed).
Audience Size
Usage description
Add to collection
Add to cart
AstraZeneca vaccine to remain authorized in Canada
Source name:
The Canadian Press
Unique identifier:
CP121635062
Legacy Identifier:
n_AstraZeneca-Vaccine-Canada20210414T1350
Type:
Video
Duration:
2m3s
Dimensions:
1920px × 1080px 142.80 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
4/14/2021 1:50:00 PM
Display aspect ratio:
16:9
Tags
AstraZeneca
COVID-19
Supriya Sharma
vaccine